Status:
UNKNOWN
Psychosocial Screening for Neuroendocrine Tumor Patients
Lead Sponsor:
Peking University
Conditions:
Neuroendocrine Tumors
Eligibility:
All Genders
18+ years
Brief Summary
This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety a...
Eligibility Criteria
Inclusion
- sign written informed consent form;
- age ≥ 18 years;
- pathologically confirmed well-differentiated neuroendocrine tumors, G1-2 (Ki67≤20%);
Exclusion
- \<18 years;
- Neuroendocrine carcinoma;
- History of psychiatric or psychologic illness;
- History of previous cancers or cancer distress;
- Patients with central nervous system(CNS) disorder；
- Severe, uncontrolled medical condition that would affect patients' compliance;
Key Trial Info
Start Date :
August 9 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 9 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03372356
Start Date
August 9 2017
End Date
August 9 2020
Last Update
December 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100142